NO852794L - 9- AND 11-SUBSTITUTED APOVINCAMIC ACID DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION - Google Patents
9- AND 11-SUBSTITUTED APOVINCAMIC ACID DERIVATIVES AND PROCEDURES FOR THEIR PREPARATIONInfo
- Publication number
- NO852794L NO852794L NO852794A NO852794A NO852794L NO 852794 L NO852794 L NO 852794L NO 852794 A NO852794 A NO 852794A NO 852794 A NO852794 A NO 852794A NO 852794 L NO852794 L NO 852794L
- Authority
- NO
- Norway
- Prior art keywords
- acid
- nitro
- salts
- apovincamic
- substituted
- Prior art date
Links
- 239000002253 acid Substances 0.000 title claims abstract description 75
- 238000000034 method Methods 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims description 12
- 150000001875 compounds Chemical class 0.000 claims abstract description 29
- 150000003839 salts Chemical class 0.000 claims abstract description 28
- 239000011541 reaction mixture Substances 0.000 claims abstract description 7
- 230000003287 optical effect Effects 0.000 claims abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 29
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 22
- 229960000583 acetic acid Drugs 0.000 claims description 14
- 239000012362 glacial acetic acid Substances 0.000 claims description 13
- 238000006396 nitration reaction Methods 0.000 claims description 11
- 238000009903 catalytic hydrogenation reaction Methods 0.000 claims description 8
- 150000002823 nitrates Chemical class 0.000 claims description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 4
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 4
- 239000003638 chemical reducing agent Substances 0.000 claims description 4
- 229910017604 nitric acid Inorganic materials 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 3
- 229910000564 Raney nickel Inorganic materials 0.000 claims description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 claims description 2
- 238000005984 hydrogenation reaction Methods 0.000 claims 1
- 238000005121 nitriding Methods 0.000 claims 1
- 229910052751 metal Chemical class 0.000 abstract description 4
- 239000002184 metal Chemical class 0.000 abstract description 4
- 150000003863 ammonium salts Chemical class 0.000 abstract 3
- 125000003277 amino group Chemical group 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 68
- 239000000243 solution Substances 0.000 description 30
- 239000000203 mixture Substances 0.000 description 16
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 229910002651 NO3 Inorganic materials 0.000 description 8
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 8
- 239000013078 crystal Substances 0.000 description 8
- 239000005457 ice water Substances 0.000 description 8
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- RXPRRQLKFXBCSJ-GIVPXCGWSA-N Vincamine Natural products C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@](O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-GIVPXCGWSA-N 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 229950006936 apovincamine Drugs 0.000 description 5
- 150000002828 nitro derivatives Chemical class 0.000 description 5
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 5
- 238000001953 recrystallisation Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000012452 mother liquor Substances 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 238000002211 ultraviolet spectrum Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- OZDNDGXASTWERN-CTNGQTDRSA-N Apovincamine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C=C(C(=O)OC)N5C2=C1 OZDNDGXASTWERN-CTNGQTDRSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- OZDNDGXASTWERN-UHFFFAOYSA-N apovincamine Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)C=C(C(=O)OC)N5C2=C1 OZDNDGXASTWERN-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- RXPRRQLKFXBCSJ-UHFFFAOYSA-N dl-Vincamin Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)CC(O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-UHFFFAOYSA-N 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 229960002726 vincamine Drugs 0.000 description 3
- HVBSAKJJOYLTQU-UHFFFAOYSA-N 4-aminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UWYVPFMHMJIBHE-OWOJBTEDSA-N (e)-2-hydroxybut-2-enedioic acid Chemical compound OC(=O)\C=C(\O)C(O)=O UWYVPFMHMJIBHE-OWOJBTEDSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- OTCCIMWXFLJLIA-UHFFFAOYSA-N N-acetyl-DL-aspartic acid Natural products CC(=O)NC(C(O)=O)CC(O)=O OTCCIMWXFLJLIA-UHFFFAOYSA-N 0.000 description 1
- OTCCIMWXFLJLIA-BYPYZUCNSA-N N-acetyl-L-aspartic acid Chemical compound CC(=O)N[C@H](C(O)=O)CC(O)=O OTCCIMWXFLJLIA-BYPYZUCNSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 229960004909 aminosalicylic acid Drugs 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- ZHGASCUQXLPSDT-UHFFFAOYSA-N cyclohexanesulfonic acid Chemical compound OS(=O)(=O)C1CCCCC1 ZHGASCUQXLPSDT-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- -1 perchloric acid Chemical class 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000005956 quaternization reaction Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 229950000244 sulfanilic acid Drugs 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Reinforced Plastic Materials (AREA)
- Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
- Slide Fasteners, Snap Fasteners, And Hook Fasteners (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Foreliggende oppfinnelse vedrører nye 9- eller 11— substituerte apovincaminsyrederivater og en fremgangsmåte for fremstilling av disse forbindelsene. Nærmere bestemt ved-rører oppfinnelsen nye, racemiske og optisk aktive nitro- og amino-apovincaminsyrederivater med formel (I) The present invention relates to new 9- or 11- substituted apovincamic acid derivatives and a method for producing these compounds. More specifically, the invention relates to new, racemic and optically active nitro- and amino-apovincamic acid derivatives of formula (I)
hvor R er en 9- eller 11-nitro- eller -aminogruppe, where R is a 9- or 11-nitro or -amino group,
og salter derav.and salts thereof.
Ifølge et annet aspekt ved oppfinnelsen tilveiebringes det en fremgangsmåte for fremstilling av de nye forbindelsene med formel (I) og salter derav. Denne fremgangsmåten omfatter nitrering av apovincaminsyre med formel (II) According to another aspect of the invention, a method is provided for the preparation of the new compounds of formula (I) and salts thereof. This process comprises the nitration of apovincamic acid of formula (II)
om ønsket, reduksjon av den erholdte 9- og/eller 11-nitro-apovincaminsyre (eventuelt etter adskillelse fra reaksjonsblandingen), og om ønsket, oppløsning av en erholdt racemisk forbindelse med formel (I) hvor R har de samme betydninger som definert ovenfor, i de optisk aktive forbindelser, og/eller, om ønsket, omdannelse av den samme forbindelse i et salt derav. 9- og 11-nitro-apovincaminsyre illustreres ved de respektive formler (Ia) og (Ib) mens de tilsvarende aminoforbindelser som fås ved reduksjon av nitroforbindelsene, illustreres ved formlene (Ic) og (Id) if desired, reduction of the obtained 9- and/or 11-nitro-apovincinamic acid (possibly after separation from the reaction mixture), and if desired, dissolution of an obtained racemic compound of formula (I) where R has the same meanings as defined above, in the optically active compounds, and/or, if desired, converting the same compound into a salt thereof. 9- and 11-nitro-apovincinamic acid are illustrated by the respective formulas (Ia) and (Ib), while the corresponding amino compounds obtained by reduction of the nitro compounds are illustrated by the formulas (Ic) and (Id)
De nye forbindelsene med formel (I) (R er som definert ovenfor) er nyttige mellomprodukter ved fremstillingen av biologisk aktive eburnanderivater som er substituert i ring A, slik som nitro-apovincaminsyreestere eller acylamino-apovincaminsyrederivater som er beskrevet hhv. i NO patent-søknad nr. 852796 og nr. 852795. The new compounds of formula (I) (R is as defined above) are useful intermediates in the preparation of biologically active eburnane derivatives which are substituted in ring A, such as nitro-apovincaminic acid esters or acylamino-apovincaminic acid derivatives which are described respectively in NO patent application no. 852796 and no. 852795.
Ifølge oppfinnelsen fremstilles forbindelser med formel (I) ved nitrering av apovincaminsyren med formel (II), og, om ønsket, en derpå følgende reduksjon av de erholdte nitroforbindelser. Apovincaminsyre er en kjent forbindelse som først ble beskrevet i HU patentskrift nr. 160 367 According to the invention, compounds of formula (I) are prepared by nitration of the apovincamic acid of formula (II), and, if desired, a subsequent reduction of the obtained nitro compounds. Apovincamic acid is a known compound that was first described in HU patent document no. 160 367
(GB patentskrift nr. 1 252 618).(GB patent document no. 1 252 618).
Det finnes ikke noen kjent fremgangsmåte innen tek-nikken for nitrering av apovincaminsyre, 9- og 11-nitro-apovincaminsyre er nye forbindelser. På den annen side er 9- og 11-nitroderivatene av vincamin og apovincamin kjente forbindelser som f.eks. kan fremstilles som beskrevet i de respektive FR patentskrifter nr. 2 341 585, 2 3 20 302 og 2 34 2 980. Både vincamin og apovincamin ble nitrert med salpetersyre i iseddik, og som et resultat ble det erholdt en blanding som inneholdt 9- og 11-nitroforbindelser i et gitt forhold. I tilfellet med vincamin favoriserte reaksjonen dannelsen av 11-nitrovincamin [Bull. Soc. Chim. Belg. 88, 1-2 (1979)], mens det ved nitrering av apovincamin ble erholdt 9-nitro-apovincamin i en større andel. Det ble ikke funnet noen effektiv fremgangsmåte for endringen av forholdet mellom de to isomerene som bare kunne adskilles ved besværlige kromatografiske fremgangsmåter på bekostning av et stort materialtap. There is no known method in the field of nitration of apovincamic acid, 9- and 11-nitro-apovincamic acid are new compounds. On the other hand, the 9- and 11-nitro derivatives of vincamine and apovincamine are known compounds such as e.g. can be prepared as described in the respective FR patent documents no. 2 341 585, 2 3 20 302 and 2 34 2 980. Both vincamine and apovincamine were nitrated with nitric acid in glacial acetic acid, and as a result a mixture containing 9- and 11-nitro compounds in a given ratio. In the case of vincamine, the reaction favored the formation of 11-nitrovincamine [Bull. Soc. Chim. Bell. 88, 1-2 (1979)], while 9-nitro-apovincamine was obtained in a larger proportion by nitration of apovincamine. No effective method was found for changing the ratio between the two isomers, which could only be separated by difficult chromatographic methods at the expense of a large loss of material.
Også ifølge oppfinnelsen nitreres apovincaminsyre fortrinnsvis med salpetersyre i et medium av iseddik. Det er imidlertid overraskende blitt funnet at ved passende valg av reaksjonsbetingelser kan forholdet mellom nitreringspro-duktene (forbindelsene med formlene (Ia) og (Ib)) påvirkes innenfor visse grenser. Dersom omsetningen utføres i ren iseddik eller i iseddik som inneholder 1 til 3% (volum/ volum) acetonitril eller dimethylformamid, fås således 9- og 11-nitro-apovincaminsyre med formlene (Ia) og (Ib) omtrent i samme mengde. På den annen side går reaksjonen i retning av 11-nitro-apovincaminsyredannelse dersom iseddiken inneholder 10 til 50% (volum/volum) kloroform. Also according to the invention, apovincamic acid is preferably nitrated with nitric acid in a medium of glacial acetic acid. However, it has surprisingly been found that by suitable choice of reaction conditions, the ratio between the nitration products (the compounds with the formulas (Ia) and (Ib)) can be influenced within certain limits. If the reaction is carried out in pure glacial acetic acid or in glacial acetic acid containing 1 to 3% (volume/volume) acetonitrile or dimethylformamide, 9- and 11-nitro-apovincamic acid with the formulas (Ia) and (Ib) are thus obtained in approximately the same amount. On the other hand, the reaction goes in the direction of 11-nitro-apovincamic acid formation if the glacial acetic acid contains 10 to 50% (volume/volume) chloroform.
Dertil kan utviklingen av nitreringen påvirkes ved å endre temperaturen. Selv om omsetningen kan utføres innenfor vide temperaturgrenser, f.eks. mellom -15 og +45°C, er det foretrukket å arbeide mellom 0 og +16°C. Ved lavere temperaturer innenfor dette temperaturintervallet er 11-nitro-apovincaminsyre rådende, og mengden av de ledsagende urenheter forblir under 5%. Rundt den øvre temperaturgrense fås de to nitroisomerene i tilnærmet like store mengder, og ■ mengden av biprodukter, som er vanskelige å identifisere, øker litt. In addition, the development of the nitration can be influenced by changing the temperature. Although the turnover can be carried out within wide temperature limits, e.g. between -15 and +45°C, it is preferred to work between 0 and +16°C. At lower temperatures within this temperature range, 11-nitro-apovincamic acid predominates, and the amount of the accompanying impurities remains below 5%. Around the upper temperature limit, the two nitroisomers are obtained in approximately equal amounts, and ■ the quantity of by-products, which are difficult to identify, increases slightly.
Dersom reaksjonen utføres mellom 0 og +16°C, er omsetningen fullstendig i løpet av ca. 2 timer. Ved å helle blandingen som fås ved nitrering over i isvann, utfelles 9-og 11-nitro-apovincaminsyre sammen i form av nitratsaltene. Det totale utbyttet av de erholdte produkter er høyt (ca. If the reaction is carried out between 0 and +16°C, the reaction is complete within approx. 2 hours. By pouring the mixture obtained by nitration into ice water, 9- and 11-nitro-apovincamic acid are precipitated together in the form of the nitrate salts. The total yield of the products obtained is high (approx.
75 til 85%). De to forbindelsene separeres fortrinnsvis ved krystallisering, via nitratsaltene. Rekrystallisering av den erholdte blanding fra en 50% vandig alkohol gir først 9-nitro-apovincaminsyrenitratet, hvoretter det rene 11-nitro-apovincaminsyrenitratet utfelles ved oppkonsentrering av modervæsken (etter utfelling av en liten mengde av et blandet produkt under henstand). Etter adskillelsen kan 9- og ll^-nitro-apovincaminsyre settes fri fra de respektive nitratsalter på en kjent måte ved oppløsning i en vandig alkalisk oppløsning og utfelling med en beregnet mengde av en syre. Nitratsaltet oppløses fortrinnsvis i en ethanol-oppløsning som er gjort alkalisk med natriumhydroxyd (50%), og det tilsvarende apovincaminsyrederivat utfelles deretter med en beregnet mengde med saltsyre. 75 to 85%). The two compounds are preferably separated by crystallization, via the nitrate salts. Recrystallization of the mixture obtained from a 50% aqueous alcohol first gives the 9-nitro-apovincamic acid nitrate, after which the pure 11-nitro-apovincamic acid nitrate is precipitated by concentration of the mother liquor (after precipitation of a small amount of a mixed product on standing). After the separation, 9- and 11^-nitro-apovincamic acid can be set free from the respective nitrate salts in a known manner by dissolution in an aqueous alkaline solution and precipitation with a calculated amount of an acid. The nitrate salt is preferably dissolved in an ethanol solution that has been made alkaline with sodium hydroxide (50%), and the corresponding apovincamic acid derivative is then precipitated with a calculated amount of hydrochloric acid.
Ifølge oppfinnelsen fremstilles aminoforbindelser med formlene (Ic) og (Id) ved reduksjon av de tilsvarende nitroforbindelser med formlene (Ia) og (Ib). According to the invention, amino compounds with the formulas (Ic) and (Id) are prepared by reduction of the corresponding nitro compounds with the formulas (Ia) and (Ib).
Blant fremgangsmåtene som er kjent fra tidligere, kan fremstillingen av 9- og 11-aminovincamin fra de tilsvarende nitroforbindelser ved katalytisk hydrogenering betraktes som analog med dette reaksjonstrinnet (se f.eks. FR patentskrift nr. 2 341 585 og 2 320 302). FR patentskrift nr. 2 342 980 beskriver også fremstillingen av 9- og 11-amino-apovincamin fra de tilsvarende nitroforbindelser ved reduksjon med sinkpulver i nærvær av calciumklorid. Ifølge de publiserte data ble omsetningen utført med oppnåelse av et middels utbytte. Among the methods known from before, the production of 9- and 11-aminovincamine from the corresponding nitro compounds by catalytic hydrogenation can be considered analogous to this reaction step (see e.g. FR patent document no. 2 341 585 and 2 320 302). FR patent document no. 2 342 980 also describes the preparation of 9- and 11-amino-apovincamine from the corresponding nitro compounds by reduction with zinc powder in the presence of calcium chloride. According to the published data, the turnover was carried out with the achievement of a medium dividend.
Studier av de tidligere kjente reaksjoner har ført oss til den konklusjon at reduksjonen av nitro-apovincaminisomerene til de tilsvarende amino-apovincaminisomerene ved katalytisk hydrogenering, bare kan utføres med et svært lavt utbytte. Hovedproduktet er et dihydroderivat som fås ved metning av 14,15-dobbeltbindingen. Studies of the previously known reactions have led us to the conclusion that the reduction of the nitro-apovincamine isomers to the corresponding amino-apovincamine isomers by catalytic hydrogenation can only be carried out with a very low yield. The main product is a dihydro derivative obtained by saturation of the 14,15-double bond.
Overraskende har vi funnet at nitro-apovincaminsyrederivatene med formlene (Ia) og (Ib) kan reduseres praktisk talt kvantitativt til de tilsvarende aminoderivater med formlene (Ic) og (Id) ved katalytisk hydrogenering. Katalytisk hydrogenering kan utføres i et alkalisk eller såvel Surprisingly, we have found that the nitro-apovincamic acid derivatives of the formulas (Ia) and (Ib) can be reduced practically quantitatively to the corresponding amino derivatives of the formulas (Ic) and (Id) by catalytic hydrogenation. Catalytic hydrogenation can be carried out in an alkaline or as well
i et surt medium, men utføres fortrinnsvis i et vandig alkoholmedium under tilnærmet nøytrale betingelser. Under slike betingelser kan det ikke iakttas noen metning av dobbeltbindingen mellom carbonatomene i 14- og 15-still-ingene. Som katalysator anvendes det fortrinnsvis palladium-på"trekull eller Raney-nikkel. Når den katalytiske hydrogenering er fullstendig, frafiltreres katalysatoren, og det in an acidic medium, but is preferably carried out in an aqueous alcohol medium under approximately neutral conditions. Under such conditions, no saturation of the double bond between the carbon atoms in the 14- and 15-positions can be observed. Palladium-on-charcoal or Raney nickel is preferably used as a catalyst. When the catalytic hydrogenation is complete, the catalyst is filtered off, and the
ønskede produkt isoleres på kjent måte, f.eks. ved inndamp-ing av oppløsningsmidlet. desired product is isolated in a known manner, e.g. by evaporation of the solvent.
Selv om katalytisk hydrogenering er foretrukket på grunn av reaksjonens enkelhet og de høye utbytter som fås, kan reduksjonen også utføres med kjemiske reduksjonsmidler (Bruckner, Gy.: Organic Chemistry II/l, 469, TankSnyvkiad6, Budapest, Ungarn, 1977). Av de beskrevne reduksjonsmidler kan de som ikke metter 14,15-dobbeltbindingen brukes ved foreliggende fremgangsmåte.Aminoforbindelsene kan således fremstilles ved Béchamp-reduksjon, men reduksjonen kan også utføres ved sink i iseddik, eller med tinn eller sink i saltsyre. Varianter av disse fremgangsmåtene som kan ut-føres i et nøytralt medium, er like godt egnet, men reduksjonen kan også utføres i et alkalisk medium, f.eks. med natriumdithionitt eller natriumsulfid, etc. Although catalytic hydrogenation is preferred because of the simplicity of the reaction and the high yields obtained, the reduction can also be carried out with chemical reducing agents (Bruckner, Gy.: Organic Chemistry II/l, 469, TankSnyvkiad6, Budapest, Hungary, 1977). Of the reducing agents described, those which do not saturate the 14,15-double bond can be used in the present method. The amino compounds can thus be prepared by Béchamp reduction, but the reduction can also be carried out with zinc in glacial acetic acid, or with tin or zinc in hydrochloric acid. Variants of these methods which can be carried out in a neutral medium are equally suitable, but the reduction can also be carried out in an alkaline medium, e.g. with sodium dithionite or sodium sulphide, etc.
Det kan konkluderes med at ved fremgangsmåten ifølge oppfinnelsen er også reduksjonstrinnet lett å utføre og gir 9- og 11-amino-apovincaminsyren i praktisk talt kvantitativt utbytte. Det er særlig fordelaktig at aminene med formlene (Ic) og (Id) som fås ved fremgangsmåten ifølge oppfinnelsen, spesielt ved katalytisk hydrogenering, kan omdannes til andre, biologisk aktive eburnanderivater, f.eks. til de tilsvarende acylamino-apovincaminsyrederivatene, direkte uten isolering fra reaksjonsblandingen. Dette skyldes den høye renheten og utmerkede utbytte ved fremgangsmåten. It can be concluded that with the method according to the invention the reduction step is also easy to carry out and gives the 9- and 11-amino-apovincamic acid in practically quantitative yield. It is particularly advantageous that the amines with the formulas (Ic) and (Id) which are obtained by the process according to the invention, especially by catalytic hydrogenation, can be converted into other, biologically active eburnane derivatives, e.g. to the corresponding acylamino-apovincinamic acid derivatives, directly without isolation from the reaction mixt. This is due to the high purity and excellent yield of the process.
Forbindelsene med formel (I) kan, om ønsket, omdannes til syreaddisjonssaltene derav ved omsetning med en syre ifølge fremgangsmåter som er i og for seg kjente. Slike syrer omfatter blant andre uorganiske syrer som f.eks. hydro-halogensyrer, f.eks. saltsyre og hydrobromsyre, svovelsyre, fosforsyre, salpetersyre, perhalogensyrer, f.eks. perklorsyre, etc, organiske carboxylsyrer som f.eks. maursyre, eddiksyre, propionsyre, oxalsyre, glycolsyre, maleinsyre, fumarsyre, hydroxymaleinsyre, ravsyre, vinsyre, ascorbinsyre, sitron-syre, eplesyre, salicylsyre, melkesyre, kanelsyre, benzosyre, fenyleddiksyre, p-aminobenzosyre, p-hydroxybenzosyre, p-aminosalicylsyre, etc, alkylsulfonsyrer som f.eks. methan- sulfonsyre, ethansulfonsyre, etc, cycloalifatiske sulfon-syrer som f.eks. cyclohexylsulfonsyre, arylsulfonsyrer som f.eks. p-toluensulfonsyre, nafthylsulfonsyre, sulfanilsyre, etc., aminosyrer som f.eks. asparaginsyre, glutaminsyre, N-acetyl-asparaginsyre, N-acetyl-glutarsyre, etc. The compounds of formula (I) can, if desired, be converted into the acid addition salts thereof by reaction with an acid according to methods which are known per se. Such acids include, among others, inorganic acids such as e.g. hydrohalic acids, e.g. hydrochloric acid and hydrobromic acid, sulfuric acid, phosphoric acid, nitric acid, perhalogenic acids, e.g. perchloric acid, etc, organic carboxylic acids such as e.g. formic acid, acetic acid, propionic acid, oxalic acid, glycolic acid, maleic acid, fumaric acid, hydroxymaleic acid, succinic acid, tartaric acid, ascorbic acid, citric acid, malic acid, salicylic acid, lactic acid, cinnamic acid, benzoic acid, phenylacetic acid, p-aminobenzoic acid, p-hydroxybenzoic acid, p-aminosalicylic acid, etc, alkylsulfonic acids such as e.g. methanesulfonic acid, ethanesulfonic acid, etc., cycloaliphatic sulfonic acids such as e.g. cyclohexylsulfonic acid, arylsulfonic acids such as e.g. p-toluenesulfonic acid, naphthylsulfonic acid, sulfanilic acid, etc., amino acids such as aspartic acid, glutamic acid, N-acetyl-aspartic acid, N-acetyl-glutaric acid, etc.
Saltdannelse kan utføres f.eks. i et inert organisk oppløsningsmiddel som f.eks. en C1 , — b, alifatisk alkohol, slik at den racemiske eller optisk aktive forbindelse med formel (I) oppløses i oppløsningsmidlet og den utvalgte syre eller en oppløsning derav dannet med det samme oppløsnings-middel, tilsettes til den første oppløsning inntil den blir svakt sur (pH 5 til 6). Deretter separeres syreaddisjons-saltet ut og kan fjernes fra reaksjonsblandingen f.eks. ved filtrering. Salt formation can be carried out e.g. in an inert organic solvent such as a C1, — b, aliphatic alcohol, so that the racemic or optically active compound of formula (I) is dissolved in the solvent and the selected acid or a solution thereof formed with the same solvent is added to the first solution until it becomes weak acidic (pH 5 to 6). The acid addition salt is then separated out and can be removed from the reaction mixture, e.g. by filtering.
Apovincaminsyrederivatene ifølge oppfinnelsen danner, på grunn av sin sure karakter, også salter med uorganiske baser. Metallsaltene fremstilles ved fremgangsmåter som er i og for seg kjente. Som uorganisk base brukes fortrinnsvis alkalimetall- eller jordalkalimetallhydroxyder som f.eks. natrium-, kalium- eller calciumhydroxyd. The apovincamic acid derivatives according to the invention, due to their acidic character, also form salts with inorganic bases. The metal salts are produced by methods which are known per se. Alkali metal or alkaline earth metal hydroxides such as e.g. sodium, potassium or calcium hydroxide.
Forbindelser med formel (I) (R er som definert ovenfor) kan også omdannes til monokvaternære salter. Kvater-nisering utføres fortrinnsvis med en ekvivalent mengde eller et lite overskudd av et tilsvarende alkylhalogenid, fortrinnsvis bromid eller jodid, i et inert oppløsningsmiddel ved forhøyet temperatur. Compounds of formula (I) (R is as defined above) can also be converted to monoquaternary salts. Quaternization is preferably carried out with an equivalent amount or a small excess of a corresponding alkyl halide, preferably bromide or iodide, in an inert solvent at elevated temperature.
Forbindelsene med formel (I) og saltene derav kan,The compounds of formula (I) and their salts can,
når de fås i form av et racemat, om ønsket, oppløses i de optisk aktive forbindelser på en i og for seg kjent måte. when they are obtained in the form of a racemate, if desired, dissolve in the optically active compounds in a manner known per se.
De racemiske eller optisk aktive forbindelser med formel (I) og saltene derav kan, om ønsket, renses ytterligere f.eks. ved rekrystallisering. Oppløsningsmidlene som brukes til rekrystallisering, velges på bakgrunn av krystal-liseringsegenskapene og oppløseligheten til forbindelsene som skal rekrystalliseres. The racemic or optically active compounds of formula (I) and their salts can, if desired, be further purified, e.g. by recrystallization. The solvents used for recrystallization are selected on the basis of the crystallization properties and solubility of the compounds to be recrystallized.
Oppfinnelsen er nærmere belyst ved hjelp av eksemplene nedenunder. The invention is explained in more detail using the examples below.
Eksempel 1Example 1
Fremstilling av (+)- 9- nitro- apovincaminsyrePreparation of (+)-9-nitro-apovincamic acid
32,2 g (0,1 mol) av (+)-apovincaminsyre ([alD +220,48, c = 2, pyridin) ble oppløst i 180 ml iseddik. Opp-løsningen ble avkjølt til 16°C, og en blanding av 52 ml iseddik og 52 ml rykende salpetersyre (spesifikk vekt: 1,52) ble tilsatt under omrøring i løpet av 5 til 15 minutter, idet det ble passet på at temperaturen burde holdes ved 16°C. Reaksjonsblandingen ble omrørt ved den samme temperatur i ytterligere 50 minutter og ble deretter helt over i 1 liter isvann. De utfelte krystaller ble frafiltrert og vasket tre ganger, hver gang med 100 ml isvann og deretter 50 ml ether. Nitratsaltet av den tilsiktede forbindelse ble erholdt som råprodukt i en mengde på 32,2 g (75%). Det urene nitratsalt ble oppløst i 800 ml av en varm 50% vandig ethanoloppløsning, avfarget med trekull, og oppløsningen fikk stå over natten. De utfelte krystallene ble frafiltrert og vasket tre ganger, hver gang med 20 ml av en 50% vandig ethanoloppløsning. Det ble erholdt 12,8 g (29%) av (+)-9-nitro-apovincaminsyrenitrat med smeltepunkt 232 til 234°C. 32.2 g (0.1 mol) of (+)-apovincinamic acid ([a1D +220.48, c = 2, pyridine) was dissolved in 180 ml of glacial acetic acid. The solution was cooled to 16°C, and a mixture of 52 ml of glacial acetic acid and 52 ml of fuming nitric acid (specific gravity: 1.52) was added with stirring over 5 to 15 minutes, taking care that the temperature should kept at 16°C. The reaction mixture was stirred at the same temperature for a further 50 minutes and then poured into 1 liter of ice water. The precipitated crystals were filtered off and washed three times, each time with 100 ml of ice water and then 50 ml of ether. The nitrate salt of the intended compound was obtained as crude product in an amount of 32.2 g (75%). The impure nitrate salt was dissolved in 800 ml of a warm 50% aqueous ethanol solution, decolorized with charcoal, and the solution was allowed to stand overnight. The precipitated crystals were filtered off and washed three times, each time with 20 ml of a 50% aqueous ethanol solution. 12.8 g (29%) of (+)-9-nitro-apovincaminic acid nitrate with melting point 232 to 234°C were obtained.
Det erholdte krystallinske stoff ble oppløst i 160 ml 50% ethanol ved 60 til 70°C mens pH i oppløsningen ble regulert til 7,5 med 1 n natriumhydroxyd. Deretter ble 10% vandig saltsyre tilsatt oppløsningen inntil pH 6,5, og de gule krystallene som skiltes ut under avkjøling, ble frafiltrert og vasket med tre 20 ml porsjoner vann. 7,4 g (20%) av (+)-9-nitro-apovincaminsyre ble erholdt. Etter rekrystallisering fra en 1:1 blanding av pyridin og ethanol smeltet produktet ved 260 til 26 2°C. The obtained crystalline substance was dissolved in 160 ml of 50% ethanol at 60 to 70°C while the pH of the solution was adjusted to 7.5 with 1 N sodium hydroxide. Then 10% aqueous hydrochloric acid was added to the solution until pH 6.5, and the yellow crystals which separated during cooling were filtered off and washed with three 20 ml portions of water. 7.4 g (20%) of (+)-9-nitro-apovincamic acid was obtained. After recrystallization from a 1:1 mixture of pyridine and ethanol, the product melted at 260 to 262°C.
[a]D= +317,32 (c = 0,4, pyridin); [α]D = +317.32 (c = 0.4, pyridine);
UV-spektrum (ethanol inneholdende 0,5 ml 1 n saltsyre)UV spectrum (ethanol containing 0.5 ml 1 N hydrochloric acid)
Anm: 210 (4,46), 287 (4,01), Notes: 210 (4.46), 287 (4.01),
<1>H-NMR-spektrum (DMSO-dg) S: Et 0,96(t)3, l,90(q)2,<1>H-NMR spectrum (DMSO-dg) S: Et 0.96(t)3, 1.90(q)2,
H-3 4,52(s)l, H-15 6,26(s)l, H-10 7,90(dd)l, (J=8 og 1Hz), H-ll 7,80(t)l (J=8Hz), H-12 7,74(dd)1 (J=8 og 1Hz). H-3 4.52(s)l, H-15 6.26(s)l, H-10 7.90(dd)l, (J=8 and 1Hz), H-ll 7.80(t) l (J=8Hz), H-12 7.74(dd)1 (J=8 and 1Hz).
Analyse for C20H21N3<0>4 (<3>67,39):Analysis for C20H21N3<0>4 (<3>67.39):
beregnet: C 65,38%, H = 5,76%, N = 11,43%,calculated: C 65.38%, H = 5.76%, N = 11.43%,
funnet: C 65,30%, H = 6,00%, N = 11,44%. found: C 65.30%, H = 6.00%, N = 11.44%.
Fra modervæsken som ble tilbake etter adskillelsen av rent (+)-9-nitro-apovincaminsyrenitrat, kunne (+)-11-nitro-apovincaminsyre isoleres ved fremgangsmåten beskrevet i eksempel 2. From the mother liquor that remained after the separation of pure (+)-9-nitro-apovincamic acid nitrate, (+)-11-nitro-apovincamic acid could be isolated by the method described in example 2.
Eksempel 2Example 2
Fremstilling av (+)- 11- nitrb- apovincaminsyrePreparation of (+)-11-nitrb-apovincamic acid
32,2 g (0,1 mol) (+)-apovincaminsyre ble oppløst i 180 ml iseddik. Til oppløsningen ble 77 ml kloroform tilsatt. Blandingen ble avkjølt til 0°C, og en blanding av 52 ml iseddik og 52 ml rykende salpetersyre (spesifikk vekt: 1,52) ble tilsatt under omrøring i løpet av 10 til 20 minutter, idet det ble passet på at temperaturen burde forbli ved 0°C. Reaksjonsblandingen ble omrørt ved den samme temperatur i ytterligere 1 time og ble deretter helt over i 1 liter isvann. Vann ble dekantert fra det erholdte tykke, klebrige materiale, og resten ble triturert med 200 til 300 ml isvann. Den vandige fase ble kastet. Krystallmassen ble triturert med 200 til 300 ml ether, filtrert, vasket tre ganger, hver gang med 100 ml isvann og deretter 50 ml ether, (på filter) og tørket. 37,8 g (85%) urent 9-nitro-apovincaminsyrenitrat ble erholdt. Det urene saltet ble oppløst i 900 ml varm 50% vandig ethanol, oppløsningen ble avfarget med trekull og fikk stå ved værelsetemperatur over natten. De utfelte krystaller ble frafiltrert og vasket tre ganger, hver gang med 20 ml 50% ethanol. 7,9 g 9-nitro-apovincaminsyrenitrat ble erholdt. Etter henstand over natten ble det utfelt noe ytterligere krystallinsk 9-nitro-apovincaminsyrenitrat fra modervæsken som ble frafiltrert og vasket med 3 10 ml porsjoner 50% vandig ethanol. Vekt: 1 g. 32.2 g (0.1 mol) of (+)-apovincinamic acid was dissolved in 180 ml of glacial acetic acid. To the solution was added 77 ml of chloroform. The mixture was cooled to 0°C, and a mixture of 52 ml of glacial acetic acid and 52 ml of fuming nitric acid (specific gravity: 1.52) was added with stirring over 10 to 20 minutes, taking care that the temperature should remain at 0°C. The reaction mixture was stirred at the same temperature for a further 1 hour and was then poured into 1 liter of ice water. Water was decanted from the resulting thick, sticky material and the residue was triturated with 200 to 300 ml of ice water. The aqueous phase was discarded. The crystalline mass was triturated with 200 to 300 ml of ether, filtered, washed three times, each time with 100 ml of ice water and then 50 ml of ether, (on filter) and dried. 37.8 g (85%) of impure 9-nitro-apovincaminic acid nitrate was obtained. The impure salt was dissolved in 900 ml of hot 50% aqueous ethanol, the solution was decolored with charcoal and allowed to stand at room temperature overnight. The precipitated crystals were filtered off and washed three times, each time with 20 ml of 50% ethanol. 7.9 g of 9-nitro-apovincinamic acid nitrate were obtained. After standing overnight, some additional crystalline 9-nitro-apovincaminic acid nitrate precipitated from the mother liquor which was filtered off and washed with 3 10 ml portions of 50% aqueous ethanol. Weight: 1 g.
Modervæsken og de blandede vaskevæsker ble oppkonsentrert til halvparten av volumet, de utfelte krystaller ble frafiltrert og vasket tre ganger med 50 ml vann hver gang. 24,9 g (58%) (+)-11-nitro-apovincaminsyrenitrat ble erholdt med smeltepunkt 211 til 214°C. The mother liquor and the mixed washing liquors were concentrated to half the volume, the precipitated crystals were filtered off and washed three times with 50 ml of water each time. 24.9 g (58%) of (+)-11-nitro-apovincaminic acid nitrate was obtained with melting point 211 to 214°C.
Det erholdte salt ble oppløst i 500 ml 50% vandig ethanol ved 60 til 70°C under tilsetning av ca. 60 ml 1 n natriumhydroxydoppløsning. Om ønsket, ble pH i oppløsningen justert til 7. De gule krystallene som ble utfelt etter avkjøling, ble frafiltrert og vasket tre ganger med 40 ml vann hver gang. 15 g (40%) 11-nitro-apovincaminsyre ble erholdt. Smeltepunkt etter rekrystallisering fra en 1:1 blanding av pyridin og ethanol: 250 til 254°C. The salt obtained was dissolved in 500 ml of 50% aqueous ethanol at 60 to 70°C with the addition of approx. 60 ml of 1 N sodium hydroxide solution. If desired, the pH of the solution was adjusted to 7. The yellow crystals that precipitated after cooling were filtered off and washed three times with 40 ml of water each time. 15 g (40%) of 11-nitro-apovincamic acid was obtained. Melting point after recrystallization from a 1:1 mixture of pyridine and ethanol: 250 to 254°C.
[a]D= +187,43 (c = 0,4, pyridin).[α]D = +187.43 (c = 0.4, pyridine).
UV-spektrum (ethanol inneholdende 0,5 ml 1 n saltsyre)UV spectrum (ethanol containing 0.5 ml 1 N hydrochloric acid)
Anm: 212 (4,32), 254 (4,13), 316 (3,98). Notes: 212 (4.32), 254 (4.13), 316 (3.98).
<1>H-NMR-spektrum (DMSO-db,) 6 : Et 0,93(t)3, 1,9 (overlapping med oppløsningsmiddeltoppen), H-3 4,20(s)l, H-15 6,20(s)l, H-9 7,60(d)l, (J = 9 Hz), H-10 7,93(dd)l (J = 9 og 2 Hz), H-12 8,38(d)1 (J = 2 Hz). <1>H-NMR spectrum (DMSO-db,) 6 : Et 0.93(t)3, 1.9 (overlap with solvent peak), H-3 4.20(s)l, H-15 6, 20(s)l, H-9 7.60(d)l, (J = 9 Hz), H-10 7.93(dd)l (J = 9 and 2 Hz), H-12 8.38( d)1 (J = 2 Hz).
Analyse for C2o<H>21N3°4 (<3>67'39):Analysis for C2o<H>21N3°4 (<3>67'39):
beregnet: C = 65,38%, H = 5,76%, N = 11,43%,calculated: C = 65.38%, H = 5.76%, N = 11.43%,
funnet: C = 65,42%, H = 5,84%, N = 11,40%. found: C = 65.42%, H = 5.84%, N = 11.40%.
Eksempel 3Example 3
Fremstilling av (-)- 9- amino- apovincaminsyrePreparation of (-)-9-amino-apovincamic acid
3,6 g (0,01 mol) (+)-9-nitro-apovincaminsyre fremstilt ifølge eksempel 1, ble oppløst i en blanding av 10 ml ethanol og 5 ml vann. Til oppløsningen ble 0,04 g av en 10% palladium-på-trekullkatalysator tilsatt, og blandingen ble omrørt i hydrogenatmosfære ved værelsetemperatur. Etter at 0,03 mol hydrogengass var blitt brukt opp, ble katalysatoren frafiltrert og vasket tre ganger med 2 ml 50% vandig ethanol hver gang. Den erholdte oppløsning kunne brukes direkte f.eks. til fremstillingen av de tilsvarende acylaminoderivater. 3.6 g (0.01 mol) of (+)-9-nitro-apovincinamic acid prepared according to example 1 was dissolved in a mixture of 10 ml of ethanol and 5 ml of water. To the solution was added 0.04 g of a 10% palladium-on-charcoal catalyst, and the mixture was stirred in a hydrogen atmosphere at room temperature. After 0.03 mol of hydrogen gas had been used up, the catalyst was filtered off and washed three times with 2 ml of 50% aqueous ethanol each time. The solution obtained could be used directly, e.g. for the production of the corresponding acylamino derivatives.
For å isolere (-)-9-aminoapovincaminsyre ble oppløs-ningen inndampet til tørrhet under vakuum. Resten ble triturert med 20 ml ethanol, de erholdte krystaller ble frafiltrert og vasket to ganger med 3 ml ethanol hver gang. To isolate (-)-9-aminoapovincinamic acid, the solution was evaporated to dryness under vacuum. The residue was triturated with 20 ml of ethanol, the crystals obtained were filtered off and washed twice with 3 ml of ethanol each time.
På denne måten ble 2,85 g (85%) av den tilsiktede forbindelse erholdt. Produktet smeltet ikke under 340°C. In this way, 2.85 g (85%) of the intended compound was obtained. The product did not melt below 340°C.
[a]D = -25 (c = 0,4, pyridin).[α]D = -25 (c = 0.4, pyridine).
UV-spektrum (ethanol inneholdende 0,5 ml 1 n saltsyre)UV spectrum (ethanol containing 0.5 ml 1 N hydrochloric acid)
Anm: 210 (4,43), 222 (4, 53), 263 (4,05), 333 (3,78).<1>H-NMR-spektrum (DMSO-dg) 5: Et: 0,93(3), ca. 1,8(2), Note: 210 (4.43), 222 (4.53), 263 (4.05), 333 (3.78).<1>H-NMR spectrum (DMSO-dg) 5 : Et: 0.93 (3), approx. 1.8(2),
H-3: 4,44s(l), Nr^OH: 4,75(3), H-15: 5,68 s(l), H-10: 6,25, H-ll, H-12: 6,72(1-1), molekylskjelettprotoner 1,2-3,4. Massespektrum M (rel.int. %) : 333(67), 308(67), 295(18), 293(55), 267(92), 264(92), 223(100). H-3: 4.44s(l), Nr^OH: 4.75(3), H-15: 5.68s(l), H-10: 6.25, H-ll, H-12: 6.72(1-1), molecular skeleton protons 1.2-3.4. Mass spectrum M (rel.int. %) : 333(67), 308(67), 295(18), 293(55), 267(92), 264(92), 223(100).
Eksempel 4Example 4
Fremstilling av (+)- 11- amino- apovincaminsyrePreparation of (+)-11-amino-apovincamic acid
3,6 g (0,01 mol) (+)-11-nitro-apovincaminsyre ble oppløst i en blanding av 5 ml ethanol og 10 ml 1 n vandig natriumhydroxydoppløsning. Til oppløsningen ble 0,04 g av en 10% palladium-på-trekullkatalysator tilsatt, og blandingen ble omrørt i hydrogenatmosfære ved værelsetemperatur. 3.6 g (0.01 mol) of (+)-11-nitro-apovincinamic acid was dissolved in a mixture of 5 ml of ethanol and 10 ml of 1 N aqueous sodium hydroxide solution. To the solution was added 0.04 g of a 10% palladium-on-charcoal catalyst, and the mixture was stirred in a hydrogen atmosphere at room temperature.
Etter at 0,03 mol (720 ml) hydrogengass var blitt brukt opp, ble katalysatoren frafiltrert og vasket tre ganger med 2 ml 50% vandig ethanol hver gang. Den erholdte oppløsning kunne, om ønsket, brukes direkte f .eks. til fremstillingen av for-skjellige acylaminoderivater. After 0.03 mol (720 ml) of hydrogen gas had been used up, the catalyst was filtered off and washed three times with 2 ml of 50% aqueous ethanol each time. The obtained resolution could, if desired, be used directly, e.g. for the production of various acylamino derivatives.
For å isolere (+)-11-amino-apovincaminsyre ble 10 mlTo isolate (+)-11-amino-apovincinamic acid, 10 ml
av en 1 n vandig saltsyreoppløsning tilsatt til oppløsningen som deretter ble konsentrert til halvparten av sitt volum i vakuum. Den oppkonsentrerte oppløsning fikk stå over natten. Det utfelte krystallinske produkt ble frafiltrert og vasket med isvann. Det ble erholdt 3,1 g (92%) av tittelforbindelsen som smeltet ved 200 til 202°C med de-komponering . of a 1N aqueous hydrochloric acid solution added to the solution which was then concentrated to half its volume in vacuo. The concentrated solution was allowed to stand overnight. The precipitated crystalline product was filtered off and washed with ice water. 3.1 g (92%) of the title compound was obtained which melted at 200 to 202°C with decomposition.
[a]D= +77,89 (c = 0,4, pyridin).[α]D = +77.89 (c = 0.4, pyridine).
UV-spektrum (ethanol inneholdende 0,5 ml 1 n saltsyre)UV spectrum (ethanol containing 0.5 ml 1 N hydrochloric acid)
Anm; 210 (4, 32), 220 (4,43), 272 (3,98), 313 (3,77).<1>H-NMR-spektrum (DMS0-dg) S : Et: 0,90t(3), ca. l,80q(2), H-3: 4,29s(l), H-15: 5,72s(l), H-9: 7,10d(l), (J = 9 Hz), H-10: 6,43dd(l), H-12: 6,64d(l) (J=2 Hz). Note; 210 (4.32), 220 (4.43), 272 (3.98), 313 (3.77).<1>H-NMR spectrum (DMS0-dg) S : Et: 0.90t(3 ), about. l.80q(2), H-3: 4.29s(l), H-15: 5.72s(l), H-9: 7.10d(l), (J = 9 Hz), H-10 : 6.43dd(l), H-12: 6.64d(l) (J=2 Hz).
Massespektrum M (C2oH23N3°2'rel'int'%): 337 (54)'308 (85)'293 (15), 267 (100). Mass spectrum M (C20H23N3°2'rel'int'%): 337 (54)'308 (85)'293 (15), 267 (100).
Eksempel 5Example 5
Fremstilling av (+)- 11- amino- apovincaminsyrePreparation of (+)-11-amino-apovincamic acid
7,3 g (0,02 mol) (+)-11-nitro-apovincaminsyre ble opp-løst i en blanding av 100 ml konsentrert saltsyre og 50 ml vann, og 7,3 g tinnpulver ble tilsatt til oppløsningen. Blandingen ble kokt i et kvarter, hvoretter oppløsningen ble dekantert fra det resterende tinn og fortynnet med 50 ml vann. Deretter ble hydrogensulfidgass ført inn i oppløs-ningen inntil utskillese av et mørkebrunt bunnfall ble iakttatt. Reaksjonsblandingen ble bragt til kokepunktet, avkjølt til 20°C, og tinnsulfidutfellingen ble frafiltrert. Den klare oppløsning ble oppkonsentrert til en tredjedel av volumet i vakuum. Den konsentrerte oppløsning fikk stå i et kjøleskap over natten. Det erholdte, krystallinske produkt ble frafiltrert og vasket med isvann. Det ble erholdt 5,8 g (86%) av den tilsiktede forbindelse. 7.3 g (0.02 mol) of (+)-11-nitro-apovincinamic acid was dissolved in a mixture of 100 ml of concentrated hydrochloric acid and 50 ml of water, and 7.3 g of tin powder was added to the solution. The mixture was boiled for fifteen minutes, after which the solution was decanted from the remaining tin and diluted with 50 ml of water. Hydrogen sulphide gas was then introduced into the solution until the separation of a dark brown precipitate was observed. The reaction mixture was brought to the boiling point, cooled to 20°C, and the stannous sulphide precipitate was filtered off. The clear solution was concentrated to one third of the volume in vacuo. The concentrated solution was allowed to stand in a refrigerator overnight. The crystalline product obtained was filtered off and washed with ice water. 5.8 g (86%) of the intended compound was obtained.
Produktet ga ingen smeltepunktnedsettelse når det ble blandet med produktet ifølge eksempel 4. The product produced no melting point depression when mixed with the product of Example 4.
Eksempel 6Example 6
Fremstilling ay kaliumsaltét av (+)- 11- nitro- apovincaminsyre Preparation of the potassium salt of (+)- 11- nitro- apovincamic acid
3,6 g (0,01 mol) (+)-11-nitro-apovincaminsyre ble oppløst i 200 ml ethanol som inneholdt 0,56 g kaliumhydroxyd. Oppløsningen ble inndampet, og resten ble rekrystallisert 3.6 g (0.01 mol) of (+)-11-nitro-apovincinamic acid was dissolved in 200 ml of ethanol containing 0.56 g of potassium hydroxide. The solution was evaporated and the residue was recrystallized
fra en blanding av 100 ml aceton og 5 ml ethanol. 3,2 g av det tilsiktede kaliumsalt ble erholdt som et gult, krystallinsk stoff. Smeltepunkt: ingen smelting opptil 340°C. from a mixture of 100 ml acetone and 5 ml ethanol. 3.2 g of the intended potassium salt was obtained as a yellow crystalline substance. Melting point: no melting up to 340°C.
Eksempel 7Example 7
Fremstilling av oxalatet av (+)- 11- nitro- apovincaminsyrePreparation of the oxalate of (+)-11-nitro-apovincamic acid
En oppløsning av 0,36 g (0,001 mol) (+)-11-nitro-apovincaminsyre i 30 ml varmt vann ble alkalisert opptil pH 7,8 med en konsentrert ammoniumhydroxydoppløsning. Den varme oppløsningen ble surgjort opptil pH 3 med en konsen-tert, vandig oppløsning av oxalsyre, og blandingen ble av-kjølt til værelsetemperatur. De erholdte krystaller ble frafiltrert og vasket med kaldt vann. 0,35 g (78%) av det tilsiktede oxalatsalt ble erholdt. Smeltepunkt: 278 til 280°C. A solution of 0.36 g (0.001 mol) of (+)-11-nitro-apovincinamic acid in 30 ml of hot water was alkalized to pH 7.8 with a concentrated ammonium hydroxide solution. The hot solution was acidified to pH 3 with a concentrated aqueous solution of oxalic acid, and the mixture was cooled to room temperature. The crystals obtained were filtered off and washed with cold water. 0.35 g (78%) of the intended oxalate salt was obtained. Melting point: 278 to 280°C.
Claims (12)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU842702A HU191693B (en) | 1984-07-11 | 1984-07-11 | Process for production of derivatives of 9-or-11 substituated apovincamin acid |
Publications (1)
Publication Number | Publication Date |
---|---|
NO852794L true NO852794L (en) | 1986-01-13 |
Family
ID=10960711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO852794A NO852794L (en) | 1984-07-11 | 1985-07-11 | 9- AND 11-SUBSTITUTED APOVINCAMIC ACID DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0173824B1 (en) |
JP (1) | JPS61118385A (en) |
KR (1) | KR910010080B1 (en) |
CN (2) | CN85105334A (en) |
AT (1) | ATE47855T1 (en) |
AU (1) | AU580787B2 (en) |
CA (1) | CA1266658A (en) |
CS (1) | CS250692B2 (en) |
DD (1) | DD236094A5 (en) |
DE (1) | DE3574141D1 (en) |
DK (1) | DK317885A (en) |
ES (1) | ES8603875A1 (en) |
FI (1) | FI81799C (en) |
GR (1) | GR851724B (en) |
HU (1) | HU191693B (en) |
IL (1) | IL75772A (en) |
IN (1) | IN163913B (en) |
NO (1) | NO852794L (en) |
NZ (1) | NZ212714A (en) |
PH (1) | PH22159A (en) |
PL (1) | PL144791B1 (en) |
PT (1) | PT80798B (en) |
SU (1) | SU1398775A3 (en) |
YU (1) | YU115285A (en) |
ZA (1) | ZA855246B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU193772B (en) * | 1985-06-12 | 1987-11-30 | Richter Gedeon Vegyeszet | Process for producing new nitro-bis-indole derivatives |
CN1042492C (en) * | 1991-10-31 | 1999-03-17 | 东北制药总厂 | Preparing method for apovincamine acid ethyl ester |
CA2238488A1 (en) * | 1994-07-07 | 1997-06-05 | Hiroyoshi Hidaka | Apovincaminic acid derivatives and drugs containing the same |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2320302A1 (en) * | 1975-08-05 | 1977-03-04 | Omnium Chimique Sa | (11)-Amino-vincamine prepd. by nitration and then redn. of vincamine - is used as a cerebral vasoregulator |
FR2341585A2 (en) * | 1976-02-20 | 1977-09-16 | Omnium Chimique Sa | Cerebral circulation regulating (9)-amino vincamine prepn. - by reducing (9)-nitro vincamine, obtd. as sec. prod. in (11)-amino vincamine prepn. |
FR2342980A1 (en) * | 1976-03-01 | 1977-09-30 | Omnium Chimique Sa | Prepn. of (9)-and (11)-amino apovincamine - by nitration and reduction of apovincamine |
HU187733B (en) * | 1982-06-30 | 1986-02-28 | Richter Gedeon Vegyeszeti Gyar Rt,Hu | Process for preparing apovincaminic acid derivatives |
HU191938B (en) * | 1984-07-11 | 1987-04-28 | Andras Vedres | Process for production of new derivatives of 9 and 11 nitro-apovincamin acid |
HU191694B (en) * | 1984-07-11 | 1987-03-30 | Richter Gedeon Vegyeszet | Process for production of new derivatives of amineburnan carbonic acid |
-
1984
- 1984-07-11 HU HU842702A patent/HU191693B/en not_active IP Right Cessation
-
1985
- 1985-07-10 AU AU44772/85A patent/AU580787B2/en not_active Ceased
- 1985-07-11 NO NO852794A patent/NO852794L/en unknown
- 1985-07-11 ZA ZA855246A patent/ZA855246B/en unknown
- 1985-07-11 ES ES545115A patent/ES8603875A1/en not_active Expired
- 1985-07-11 FI FI852749A patent/FI81799C/en not_active IP Right Cessation
- 1985-07-11 KR KR1019850004953A patent/KR910010080B1/en not_active IP Right Cessation
- 1985-07-11 NZ NZ212714A patent/NZ212714A/en unknown
- 1985-07-11 SU SU853920150A patent/SU1398775A3/en active
- 1985-07-11 PT PT80798A patent/PT80798B/en not_active IP Right Cessation
- 1985-07-11 CA CA000486674A patent/CA1266658A/en not_active Expired - Fee Related
- 1985-07-11 DE DE8585108625T patent/DE3574141D1/en not_active Expired
- 1985-07-11 IN IN545/DEL/85A patent/IN163913B/en unknown
- 1985-07-11 IL IL75772A patent/IL75772A/en not_active IP Right Cessation
- 1985-07-11 DD DD85278515A patent/DD236094A5/en not_active IP Right Cessation
- 1985-07-11 CS CS855185A patent/CS250692B2/en unknown
- 1985-07-11 JP JP60151429A patent/JPS61118385A/en active Granted
- 1985-07-11 PH PH32511A patent/PH22159A/en unknown
- 1985-07-11 GR GR851724A patent/GR851724B/el unknown
- 1985-07-11 EP EP85108625A patent/EP0173824B1/en not_active Expired
- 1985-07-11 AT AT85108625T patent/ATE47855T1/en not_active IP Right Cessation
- 1985-07-11 DK DK317885A patent/DK317885A/en not_active Application Discontinuation
- 1985-07-11 PL PL1985254498A patent/PL144791B1/en unknown
- 1985-07-11 YU YU01152/85A patent/YU115285A/en unknown
- 1985-07-12 CN CN198585105334A patent/CN85105334A/en active Pending
- 1985-08-10 CN CN198585106058A patent/CN85106058A/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT95099B (en) | PROCESS FOR THE PREPARATION OF AMINO CYCLIC ACIDS AS WELL AS OF THEIR INTERMEDIARIES | |
EP0077754A2 (en) | Novel pharmaceutically active 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinoline derivatives | |
SU719499A3 (en) | Method of preparing 1,2,3,4,6,7-hexahydro-11 b alpha-h-benzo(alpha)-quinolysin derivatives or their salts | |
NO135751B (en) | ||
NO852794L (en) | 9- AND 11-SUBSTITUTED APOVINCAMIC ACID DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION | |
NO317997B1 (en) | Process for Preparation of a Naphthyridine Carboxylic Acid Derivative (Methanesulfonate Sesquihydrate) | |
Kametaka et al. | CXXX.—Carthamine. Part I | |
SU545260A3 (en) | Method for preparing octahydroindoloquinolizin derivatives or their salts, or racemate, or optical antipodes | |
NO128533B (en) | ||
Yamada et al. | Preparation of d-p-Hydroxyphenylglycine: Optical Resolution of dl-p-Hydroxyphenylglycine by Preferential Crystallization Procedure | |
SU554816A3 (en) | The method of obtaining nitrogen-containing polycyclic compounds or their salts, or racemates, or optical antipodes | |
Akkerman et al. | Synthetic oxytocics. IV. 3‐(piperidyl‐(2)‐methyl‐) indoles and related compounds | |
US2796419A (en) | Lysergic acid, intermediates and preparation | |
US4052404A (en) | Indolo (2,3-α)quinolizines | |
US4322360A (en) | Process for producing imidazolidone intermediates of biotin | |
US4521616A (en) | Method for the preparation of fluoroanthranilic acids | |
JPS6148839B2 (en) | ||
NO149353B (en) | PROCEDURE FOR PREPARING 6-CHLORO-ALFA-METHYL CARBZOL-2-ACETIC ACID | |
US4048211A (en) | Modification of methadone synthesis process step | |
Abarca et al. | Triazolopyridines. Part 9. The synthesis of7-amino (1, 2, 3) triazolo (1, 5-a) pyridines | |
NO140302B (en) | PROCEDURES FOR THE PREPARATION OF PHTHALAZINO (2,3-B) -FTALAZIN-5 (14H), 12 (7H) -DION | |
NO802101L (en) | PROCEDURE FOR PREPARING 15-HYDROXYIMINO-E-HOMO-EBURNAND DERIVATIVES. | |
EP0050492A1 (en) | 1,1-Disubstituted-hexahydro-indolo(2,3-a)quinolizine derivatives and their use in the enantioselective synthesis of optically active 14-oxo-E-homo-eburnane derivatives | |
NO763062L (en) | ||
CS250700B2 (en) | Method of 9 or 11- substituted apovincamine acid's racemic and optically active derivatives preparation |